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Zinc disrupts central carbon 
metabolism and capsule 
biosynthesis in Streptococcus 
pyogenes
Cheryl-lynn Y. Ong, Mark J. Walker* & Alastair G. McEwan*
Neutrophils release free zinc to eliminate the phagocytosed bacterial pathogen Streptococcus 
pyogenes (Group A Streptococcus; GAS). In this study, we investigated the mechanisms underpinning 
zinc toxicity towards this human pathogen, responsible for diseases ranging from pharyngitis and 
impetigo, to severe invasive infections. Using the globally-disseminated M1T1 GAS strain, we 
demonstrate that zinc stress impairs glucose metabolism through the inhibition of the glycolytic 
enzymes phosphofructokinase and glyceraldehyde-3-phosphate dehydrogenase. In the presence of 
zinc, a metabolic shift to the tagatose-6-phosphate pathway allows conversion of D-galactose to 
dihydroxyacetone phosphate and glyceraldehyde phosphate, partially bypassing impaired glycolytic 
enzymes to generate pyruvate. Additionally, zinc inhibition of phosphoglucomutase results in 
decreased capsule biosynthesis. These data indicate that zinc exerts it toxicity via mechanisms that 
inhibit both GAS central carbon metabolism and virulence pathways.
Zinc is a significant factor in the innate immune defence against pathogens1. This metal ion is an abso-
lute nutritional requirement for the growth of all cells and it is essential for the activity of a wide vari-
ety of enzymes2. The ability of the host to withhold zinc from the bacterial pathogen is an important 
aspect of nutritional immunity and it is exemplified by the action of the human protein calprotectin3,4. 
Calprotectin has a high affinity for zinc and the sequestration of this critical metal ion leads to starvation 
of the bacterial pathogen5. Nonetheless, it is also established that zinc deficiency in humans is linked 
to increased susceptibility to bacterial infections6. This increased susceptibility has been ascribed to a 
decrease in the capability of the innate immune system as a consequence of zinc limitation6. Altered 
levels of zinc have been measured during inflammation and high levels of zinc result in the activation 
of various immune cells, leading to the suggestion that zinc may have an additional signalling role in 
relation to host defence against pathogens7.
Approximately 15% of zinc has been described as labile (readily available) in the airway mucosal 
epithelium8 and also specific sites of infection where recruitment of innate immune cells can result in 
an influx of zinc9,10. Recently, in a landmark study, Botella and co-workers demonstrated that zinc is 
trafficked to the phagosome of macrophages infected with Mycobacterium tuberculosis, indicating that 
elevated zinc may play a more direct antimicrobial role9. Subsequently, it has been demonstrated that 
internalization of Streptococcus pyogenes (Group A Streptococcus; GAS) triggers the release of zinc within 
human neutrophils10. The zinc-specific cation diffusion facilitator, CzcD, was found essential for bacterial 
resistance against zinc-mediated killing by human neutrophils10. Furthermore, deletion of czcD resulted 
in reduced virulence in a murine infection model of GAS invasive disease10. These data are consistent 
with a direct antimicrobial effect of zinc on bacteria during infection.
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How might zinc exert an antimicrobial effect? Recently, McDevitt and co-workers showed that in 
Streptococcus pneumomoniae, zinc prevents the uptake of manganese by binding irreversibly to the high 
affinity manganese solute binding protein PsaA11,12. As a consequence, S. pneumoniae becomes hyper-
sensitive to oxidative stress12. Although an analogous manganese uptake system is present in GAS, the 
observation that loss of a zinc-efflux pump leads to decreased survival10 suggests that the zinc ions 
may also exert a direct antimicrobial effect within the cytoplasm of the bacteria. Therefore, to investi-
gate the mechanism by which zinc mediates bacterial toxicity, we have employed the clinically-relevant, 
globally-disseminated M1T1 strain of GAS. Our findings indicate that elevated zinc disrupts virulence 
through the reduction of hyaluronic acid capsule biosynthesis. Additionally, zinc inhibits key enzymes of 
glucose catabolism, leading to a shift in expression of central carbon catabolic pathways.
Results
Zinc inhibition of the growth of GAS with glucose as carbon source. Studies of bacterial path-
ogens often make use of a complex growth medium where phenotypic and physiological effects of sup-
plemented compounds such as transition metal ions are dampened13,14. Therefore, to overcome these 
problems, we designed a medium, BHP-glucose, with reduced nutrients compared to THY to allow for 
maximum utilization of the carbon source under investigation. With increasing concentrations of zinc, 
the growth rate and biomass formed by the GAS strain M1T1 isolate 5448 is reduced (Fig. 1a). At a zinc 
concentration of 100 μ M in BHP-glucose medium, growth of GAS was inhibited. To achieve the same 
level of inhibition in complex THY medium, a concentration of 1.5 mM is required10.
Previous studies have suggested that zinc can inhibit specific enzymes in the glycolysis 
(Embden-Meyerhof) pathway15. Thus, we measured the enzymatic activity of phosphofructokinase 
(PFK) and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) under varying zinc concentrations 
during growth of GAS, and in vitro following addition of zinc to cell free extracts. The activity of PFK 
was significantly impaired in cells grown in the presence of 50 μ M zinc compared to cells grown without 
zinc supplementation (P < 0.05, Fig. 1b). Furthermore, the addition of 500 μ M zinc to cell free extracts 
reduced enzyme activity by 3-fold (P < 0.01, Fig. 1c). The activity of GAPDH was even more susceptible 
to zinc; in cells grown in the presence of 50 μ M zinc there was 5-fold less activity compared to cells 
grown without addition of zinc (P < 0.01, Fig. 1d). Addition of zinc to cell free extracts also dramatically 
inhibited GAPDH activity (Fig.  1e). Therefore, our results are consistent with the hypothesis that zinc 
may exert toxicity towards GAS by inhibiting glycolysis, resulting in impaired growth. To confirm that 
the zinc inhibition observed was not due to a zinc-induced inability to import glucose, measurements 
of total glucose was undertaken at the start-, mid- and end-point of cells grown in BHP-glucose with 
increasing zinc concentrations. The results indicate that zinc does not inhibit glucose uptake in GAS 
(Supplementary Fig. 1), and the impaired growth was clearly due to the inhibition of glycolysis.
Changes in GAS gene expression in response to zinc stress. To determine the global response 
of GAS to zinc, a transcriptome analysis was performed comparing the gene expression profile of the 
wild-type 5448 strain grown in THY in the presence and absence of 1 mM zinc. THY medium was 
used in this analysis to provide a rich growth environment for GAS, thereby reducing dependence on a 
single carbon source. Under these conditions, the level of zinc chosen to achieve a comparable level of 
sub-inhibitory toxicity as observed in BHP-glucose was 1 mM, a concentration previously shown to be 
sub-inhibitory in THY medium10. A total of 56 genes exhibited increased expression in the presence of 
zinc and 17 genes showed reduced expression (Supplementary table 1). Amongst the up-regulated genes, 
the lac.2 operon and the galactose phosphotransferase (PTS) gene, lacF, showed increased expression in 
the presence of zinc (Table 1). Quantitative reverse-transcriptase PCR (qPCR) was performed on GAS 
cells grown in BHP-glucose in the absence and presence of 50 μ M zinc to validate the microarray data 
obtained using THY medium containing 1 mM zinc. The qPCR results confirmed that the lac.2 operon 
genes were upregulated in the presence of zinc (Supplementary Fig. 2). These data suggested a switch from 
glucose metabolism in the presence of zinc, to utilization of galactose as an alternative carbon source. 
GAS lacks the enzymes of the Leloir pathway (for the conversion of D-galactose to UDP-galactose) 
but can utilize the tagatose-6-phosphate pathway to convert D-galactose to dihydroxyacetone phosphate 
(DHAP) and glyceraldehyde phosphate (GAP) to partially bypass glycolysis to generate pyruvate. The 
first step in the tagatose-6-phosphate is the conversion of D-galactose to galactose-6-phosphate and 
then to tagatose-6-phosphate by galactose-6-phosphate isomerase (LacAB.2). The tagatose-6-phosphate 
is then converted to tagatose-1,6-bisphosphate by tagatose-6-phosphate kinase (LacC.2) and then finally 
converted to DHAP and GAP by tagatose-bisphosphate aldolase (LacD.2) (Table 1).
Galactose utilization circumvents the zinc inhibited glucose utilization pathway in GAS. In 
view of the transcriptome data suggesting a potential switch in carbon metabolism, we investigated 
whether growth on galactose was less susceptible to zinc inhibition. Unlike the growth in BHP-glucose 
(Fig. 1a), GAS cells grown in BHP-galactose were less sensitive to zinc inhibition (Fig. 2a, Supplementary 
Fig. 3). The specific growth rates between GAS cells grown in BHP-glucose compared to BHP-galactose 
were similar, 0.48 and 0.47 h−1, respectively (P > 0.05; Supplementary Fig. 3b). However, the specific 
growth rate of GAS cells grown in BHP-glucose containing 75 μ M zinc was 4-fold lower than GAS grown 
in BHP-galactose with 75 μ M zinc, 0.02 compared to 0.08 h−1, respectively (P < 0.0001; Supplementary 
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Figure 1. Growth of Group A Streptococcus in glucose and zinc results in inhibition of glycolytic 
enzymes. (a) Growth curve analysis of GAS 5448 WT in BHP-glucose supplemented with 0 (black circles), 
25 (dark grey circles), 50 (light grey circles), 75 (white circles), 100 (red circles) μ M zinc. Graph is a 
representative of three independent experiments. (b) PFK activity assay performed on GAS cell-free extracts 
of cells grown in BHP-glucose in the absence and presence of 50 μ M zinc. Unpaired, 2-tailed t-tests were 
performed; *P < 0.05. (c) PFK activity assay performed on GAS cell-free extracts of cells grown in BHP-
glucose. Cell-free extracts were incubated with 50–500 μ M zinc for 10 min prior to the assay. Unpaired, 
2-tailed t-tests were performed 0 vs. 500 μ M zinc; **P < 0.01. (d) GAPDH activity assay performed on 
GAS cell-free extracts of cells grown in BHP-glucose in the absence and presence of 50 μ M zinc. Unpaired, 
2-tailed t-tests were performed; **P < 0.01. (e) GAPDH activity assay performed on GAS cell-free extracts 
of cells grown in BHP-glucose. Cell-free extracts were incubated with 50-500 μ M zinc for 10 min prior to 
the assay. Unpaired, 2-tailed t-tests were performed on 0 vs. 50 μ M zinc, and 0 vs. 500 μ M zinc; **P < 0.01. 
Samples were collected during exponential phase of growth and error bars are indicative of the standard 
deviation of three independent experiments.
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Fig. 3b). The same growth analyses were performed with other transition metal ions and no differential 
effect was observed between their sensitivities when grown in BHP-glucose compared to BHP-galactose 
(Supplementary Fig. 4), indicating that the growth inhibition in glucose is zinc-specific. Furthermore, 
the concentrations required for any minimal growth inhibition of GAS for all other metals tested was 
substantially higher than the concentration required for zinc-mediated growth inhibition.
Since transcription of the lac.2 operon genes were increased in the presence of zinc, we proceeded to 
measure the enzymatic activity of tagatose-6-phosphate kinase (LacC.2) under varying zinc concentra-
tions during growth of GAS, and in vitro following addition of zinc to cell free extracts. The activity of 
LacC.2 was significantly increased in cells grown in the presence of 50 μ M zinc compared to cells grown 
without zinc supplementation (P < 0.01, Fig. 2b). However, unlike the PFK and GAPDH enzymes, the 
incubation of cell free extracts with 500 μ M zinc did not significantly change the enzyme activity of 
LacC.2 (P > 0.05, Fig. 2c). These combined data suggest that the tagatose-6-phosphate pathway may be 
more resistant to high levels of zinc, and is upregulated when such conditions are encountered.
Previous studies have identified that GAS cells grown on different carbon sources result in different 
end product metabolites16. Therefore, we measured the metabolites produced by GAS during growth in 
BHP-glucose and BHP-galactose in the absence and presence of 50 μ M zinc. In general, we found that 
growth in galactose resulted in decreased lactate (P < 0.01) and increased acetate (P < 0.001) and ethanol 
(P < 0.05) formation compared to growth in glucose (Fig. 2d). Growth in the presence of zinc resulted in 
a further increase of ethanol formation regardless of the carbon source (P < 0.01) and also a decrease in 
lactate formation (P < 0.001) when grown in glucose (Fig. 2d). This result indicates that the presence of 
zinc causes a shift in carbon source utilization and consequently, a shift in the end product metabolites. 
This was further supported by qPCR of the acetaldehyde/alcohol dehydrogenase gene (adh2), which 
converts acetyl-CoA to ethanol via acetaldehyde (Fig. 2e). These data show that growth in the presence of 
zinc results in the 3-fold up-regulation of adh2. In contrast the adhA gene that encodes a dehydrogenase 
involved in the oxidation of ethanol exhibited a 2-fold down-regulation (Fig. 2e).
Zinc toxicity in GAS results in decreased hyaluronic acid capsule production. When glucose 
enters the cell, it can be used for a variety of biochemical processes, including nucleotide sugar metab-
olism. The first enzyme in this pathway, phosphoglucomutase (PGM), has also been identified as an 
enzyme susceptible to inhibition by zinc17. PGM converts glucose-6-phosphate to glucose-1-phosphate, 
which is then converted to UDP-glucose and UDP-glucuronic acid, precursors of the hyaluronic acid 
capsule of GAS. To determine if PGM in GAS is inhibited by zinc, we measured its enzymatic activity in 
the presence and absence of zinc. PGM activity was significantly reduced in GAS grown in the presence 
of 50 μ M zinc (P < 0.01, Fig. 3a).Furthermore, when cell-free extracts of GAS cells grown in the absence 
of zinc were incubated with zinc 10 min prior to the assay, enzymatic activity was also significantly 
reduced in vitro with the addition of 50 and 500 μ M zinc (P < 0.05 and P < 0.01, respectively; Fig. 3b). 
This result suggests that the decrease in PGM activity was not due to the secondary effects caused by 
reduced growth in the presence of zinc. We additionally assessed total hyaluronic acid content to deter-
mine if growth in zinc results in decreased hyaluronic acid capsule. Hyaluronic acid content decreased 
approximately 2-fold in cells grown in 25 μ M zinc (P < 0.01), and further decreased by 5-fold in cells 
grown in 50 μ M zinc (P < 0.05) (Fig.  3c). This result correlates with the decrease in PGM activity and 
suggests zinc toxicity results in reduction of hyaluronic acid capsule in GAS.
Locus Gene/Locus Function Zn+/Zn- P-Value q-Value
Galactose transport
 M5005_
Spy1633 lacE
PTS system, lactose-specific 
IIBC component 2.792 0.000 0.028
 M5005_
Spy1634 lacF
PTS system, lactose-specific IIA 
component 2.754 0.000 0.031
Enzymes involved in Tagatose-6-P/Galactose-6-P metabolism
 M5005_
Spy1635 lacD.2 Tagatose-bisphosphate aldolase 2.609 0.000 0.030
 M5005_
Spy1636 lacC.2 Tagatose-6-phosphate kinase 2.570 0.000 0.034
 M5005_
Spy1637 lacB.2
Galactose-6-phosphate isomerase 
lacB subunit 2.700 0.000 0.030
 M5005_
Spy1638 lacA.2
Galactose-6-phosphate isomerase 
lacA subunit 2.331 0.001 0.048
 M5005_
Spy1639 lacR.2
Lactose phosphotransferase 
system repressor 2.016 0.003 0.119
Table 1.  Table of genes up-regulated by zinc involved in galactose transport and utilization.
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Discussion
GAS is a host-adapted obligate human pathogen responsible for a wide spectrum of diseases. GAS can 
colonize the skin and throat asymptomatically or cause mild superficial infections such as impetigo and 
pharyngitis. GAS can also penetrate into deeper tissues resulting in severe invasive diseases such as sep-
ticaemia, necrotizing fasciitis, and streptococcal toxic shock-like syndrome18. GAS is estimated to cause 
more than 18 million cases of severe disease and over 500,000 human deaths per year18.
Figure 2. Zinc stress in Group A Streptococcus results in a shift in carbon metabolism. (a) Growth curve 
analysis of GAS 5448 WT in BHP-galactose supplemented with 0 (black circles), 25 (dark grey circles), 
50 (light grey circles), 75 (white circles), 100 (red circles) μ M zinc. Graph is a representative of three 
independent experiments. (b) Tagatose-6-phosphate kinase (LacC.2) activity assay performed on GAS cell-
free extracts of cells grown in BHP-glucose in the absence and presence of 50 μ M zinc. Unpaired, 2-tailed 
t-tests were performed; **P < 0.01. (c) Tagatose-6-phosphate kinase (LacC.2) activity assay performed on 
GAS cell-free extracts of cells grown in BHP-glucose. Cell-free extracts were incubated with 500 μ M zinc for 
10 min prior to the assay. Unpaired, 2-tailed t-tests were performed; ns = not statistically significant. Samples 
for enzyme activity were collected during exponential phase of growth and error bars are indicative of the 
standard deviation of three independent experiments. (d) End metabolite measurement of cells grown in 
either BHP-glucose or BHP-galactose in the presence and absence of 50 μ M zinc. Cells were grown up to 
stationary phase in the described medium, supernatant collected, filtered and measured for L-lactate, acetate 
and ethanol. Graph is a representative of three independent experiments. Unpaired, 2-tailed t-tests were 
performed on: Lactate – glucose vs. galactose, glucose 0 vs. 25 μ M zinc; Acetate – glucose vs. galactose; 
Ethanol – glucose vs. galactose, glucose 0 vs. 50 μ M zinc, galactose 0 vs. 50 μ M; ***P < 0.001, **P < 0.01, 
*P < 0.05. (e) Relative gene expression of the alcohol dehydrogenase genes, adhA and adh2 (direction of 
reaction as indicated). Cells were grown up to mid-exponential phase in BHP-glucose in the presence and 
absence of 50 μ M zinc, error bars are indicative of the standard deviation of 3 independent experiments. 
Relative gene expression was calculated using the 2−ΔCT method, with gyrA as the reference gene, and results 
are represented as fold change of expression from growth in zinc compared to growth without zinc.
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Zinc has recently been shown to be released by immune cells to combat intracellular pathogens 
including GAS10, however, the mechanism of zinc toxicity has not been previously described. Zinc is 
a critical metal ion for the nutrition and growth of all living organisms and it is the most abundant 
transition metal ion, being found in approximately 6% of proteins in bacteria19. Zinc within bacteria 
is allocated to enzymes and other proteins but the intracellular concentration of free zinc is usually 
kept very low and tightly regulated, as a consequence of zinc homeostasis20. GAS possesses two zinc 
uptake systems, AdcABC and Lsp (or AdcAII), regulated by AdcR21,22 that respond to zinc limitation. 
GAS also expresses a zinc efflux pump, CzcD, which is regulated by the GAS CzcD transcriptional acti-
vator, GczA10. By tightly controlling intracellular zinc, GAS should avoid zinc-mediated disruption of 
cell function. We have previously shown that deletion of the zinc efflux system in GAS caused a severe 
growth defect when challenged with zinc, elevated susceptibility to human neutrophil killing and loss 
of virulence in the murine model of invasive disease10. This suggests that high levels of zinc are toxic to 
GAS and that this is a condition encountered upon phagocytosis of GAS by immune cells. Here we have 
shown that zinc affects growth of GAS by decreasing its ability to use glucose as a carbon source as a 
consequence of the inhibition of two key enzymes of glycolysis, PFK and GAPDH (Fig. 1). This effect 
was exerted both at the level of enzyme function (Fig. 1b–e), and gene expression (Supplementary Fig. 
5). In corroboration with our findings, excess zinc has previously been shown to inhibit glycolysis and 
glucose metabolism in various oral streptococcal species23,24.
Glucose is metabolized in GAS via the glycolytic pathway since it lacks the Entner-Doudoroff path-
way25. The response of GAS to zinc appears to involve a switch in carbon metabolism to favor galactose 
utilization. We found that zinc toxicity in GAS is less pronounced when grown on galactose compared to 
glucose, and that this is a zinc-specific effect (Supplementary Fig. 3 and 4). Transcriptome data revealed 
that under zinc stress, the galactose/tagatose-6-phosphate metabolism is induced (Table 1, Supplementary 
Fig. 2). Furthermore, we confirmed that the LacC.2 activity and the lacC.2 gene expression are increased 
when GAS is grown in the presence of zinc (Fig.  2b; Supplementary Fig. 2). Interestingly, a microar-
ray study in E. coli comparing gene expression profiles of the cells grown in the absence and pres-
ence of N,N,N’,N’-tetrakis(2-pyridylmethyl)ethane-1,2-diamine (TPEN), a zinc chelator, identified the 
down-regulation of genes in the galactose/tagatose-6-phosphate metabolism during zinc starvation26. 
This further suggests a link between zinc homeostasis and central carbon metabolism. GAS possesses two 
Figure 3. Growth of Group A Streptococcus in glucose and zinc results in decreased hyaluronic acid 
capsule. (a) PGM activity assay performed on GAS cell-free extracts of cells grown in BHP-glucose in the 
absence and presence of 50 μ M zinc. Unpaired, 2-tailed t-tests were performed; **P < 0.01. (b) PGM activity 
assay performed on GAS cell-free extracts of cells grown in BHP-glucose. Cell-free extracts were incubated 
with 50–500 μ M zinc for 10 min prior to the assay. Unpaired, 2-tailed t-tests were performed on 0 vs. 50 μ M 
zinc, and 0 vs. 500 μ M zinc; *P < 0.05, **P < 0.01. (c) Total hyaluronic acid measured on GAS cells grown in 
BHP-glucose in the absence and presence of 25 and 50 μ M zinc. Unpaired, 2-tailed t-tests were performed 
on 0 vs. 25 μ M zinc, and 0 vs. 50 μ M zinc; **P < 0.01, *P < 0.05. All samples were collected during 
exponential phase of growth and error bars are indicative of the standard deviation of three independent 
experiments.
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lac operons (lac.1 and lac.2). Whilst the lac.1 operon is not directly involved in galactose metabolism but 
appears to have a regulatory role, the lac.2 operon is inducible and required for growth on galactose27–29. 
The enzymes in the galactose/tagatose-6-phosphate pathway convert imported galactose into metabolites 
that feed into glycolysis. It is also notable that at mucosal surfaces such as the airway epithelial and naso-
pharynx, a common niche for GAS, glucose concentration is low but galactose is readily available from 
mucins30,31. Furthermore, the membranes at these mucosal surfaces are sites of concentrated exchangea-
ble zinc pools8,32. Therefore, with the abundance of zinc at mucosal sites, GAS may upregulate galactose 
metabolism and bypass the zinc inhibition of glucose utilization, resulting in the utilization of a carbon 
source readily available from the host.
Studies have demonstrated that a shift from glucose to galactose utilization also results in a shift from 
homolactic fermentation (mainly lactate production) to mixed-acid fermentation (acetate, ethanol and 
formate production)16. Therefore, not surprisingly, our results show a shift in end-product metabolites 
resulting in increased ethanol production in the presence of zinc (Fig. 2d). Ethanol production in GAS 
can occur under aerobiosis by the pyruvate dehydrogenase complex or under microaerobic and anaer-
obic conditions by the oxygen-sensitive pyruvate formate lyase25. The host tissue environment favors 
mixed-acid fermentation due to the limited free and readily-fermentable sugars such as glucose, the 
abundance of glycoproteins with O and N-linked glycans that contain monosaccharides such as galactose 
and the hypoxic nature of deep tissue sites31. Combined, these observations have allowed us to build a 
model for zinc toxicity in GAS (Fig.  4) and suggest that zinc can act as a signal that regulates carbon 
metabolism and virulence in GAS.
Another enzyme that is inhibited by zinc is PGM. Elevated zinc levels led to a decrease in hyaluronic 
acid capsule formation. Glucose 1-P, the product of PGM, is required to generate UDP-glucose that 
forms the building blocks of hyaluronic acid, the capsular polysaccharide of GAS33,34. It has been shown 
that in GAS, growth on galactose instead of glucose results in decreased hyaluronic acid formation due 
to the reduction of UDP-sugar precursors16,35. Furthermore, deletion of PGM resulted in reduced capsule 
in Streptococcus iniae and decreased virulence of both S. iniae and S. pneumoniae36,37. It is well established 
that the hyaluronic acid capsule is associated with GAS virulence and its ability to resist phagocytic kill-
ing38–40. For example, an M1 GAS strain with a four-fold increase in capsule production had increased 
ability to disseminate into tissues, survive in human blood and resist neutrophil killing41. Likewise, GAS 
M-types that produces lower levels of capsule have reduced capacities to resist phagocyte killing42–45. 
Figure 4. Proposed model demonstrating the effects of zinc on the physiology of GAS. Zinc stress 
results in inhibition of enzymes involved in glycolysis and capsule biosynthesis. As a result, the adaptive 
response of GAS to zinc stress is to switch from glucose to galactose utilization. PGI = phosphoglucose-6 
isomerase; PFK = phosphofructokinase; GAPDH = glyceraldehyde-3-phosphate dehydrogenase; 
PGM = phosphoglucomutase; FBP = fructose-1,6,-bisphosphate; DHAP = dihydroxyacetone phosphate; 
GAP = glyceraldehyde-3-phosphate; PGM = phosphoglucomutase; HasC = UTP-glucose-1-phosphate 
uridylyltransferase; Has B = UDP-glucose-6 dehydrogenase. Zinc ions depicted by blue circles.
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Therefore, it is not surprising that in our previous study, deletion of the zinc efflux transporter CzcD, 
resulted in decreased virulence in the murine model of invasive disease10.
Our observations raise the question of the infection sites and timing during GAS infection in which 
zinc sequestration by the host plays a role in defense against infection versus the use of zinc by the host as 
an antimicrobial agent. It has been shown that a GAS lsp mutant that lacks the high affinity zinc acquisi-
tion system is attenuated in a murine subcutaneous ulcer model of infection, indicating that under these 
conditions zinc acquisition is critical for GAS infection22. Such a phenomenon may be explained through 
the sequestration of zinc by calprotectin released from neutrophils to impede microbial growth. Zinc 
sequestration as an antimicrobial strategy has been observed in the gut during infection with Salmonella 
enterica and Helicobacter pylori46,47. Our recent observations suggest that zinc plays a role in neutrophil 
killing and under those conditions, intracellular calprotectin may not play an antimicrobial role against 
GAS10. Furthermore, mucosal membranes containing secretory cells such as the airway epithelial and 
nasopharynx, common niches of GAS colonization, are sites of concentrated exchangeable zinc pools8,32. 
Combined, these observations support the hypothesis that zinc plays a central role in controlling bacte-
rial infections through both sequestration and antimicrobial activity.
Methods
Bacterial strains and growth conditions. The S. pyogenes M1T1 clinical isolate 544848 were rou-
tinely grown on 5% horse blood agar or statically in liquid cultures at 37 °C in Todd Hewitt broth sup-
plemented with 1% yeast extract (THY). For physiological and enzymatic assays, cells were grown up in 
1% brain heart infusion broth supplemented with 0.5% peptone (BHP) with the addition of either 1% 
D-glucose or D-galactose (BHP-glucose, BHP-galactose, respectively). When growing cultures in BHP 
overnight for subculturing the following day, 0.2% (w/v, final concentration) sodium bicarbonate was 
added prior to the inoculation of bacteria.
Transcriptome analysis. M1T1 GAS 5448 was grown up in THY in the absence or presence of 
1 mM zinc to mid-exponential phase (optical density ~0.6). Glass slide DNA microarrays were obtained 
from the Pathogen Functional Genomics Research Center (sponsored by the U.S. National Institute of 
Allergy and Infectious Diseases) at the J. Craig Venter Institute (Rockville, MD, USA). All probes rep-
resenting the GAS M1T1 strain MGAS5005 ORFs were used for analysis. Total RNA was isolated using 
the RNeasy mini kit (Qiagen) and Cy3-labeled cDNA generated using the Fairplay microarray labelling 
kit (Stratagene). Single-colour hybridizations were performed according to the supplier’s instructions 
(http://pfgrc.jcvi.org/index.php/microarray/protocols.html). Slides were scanned using a GenePix 4000B 
scanner (Axon Instruments) and analysed using GenePixPro 4.0 software (Axon Instruments). Data 
from each microarray has undergone strict threshold and normalization as described49, and statistical 
analysis was performed using the MultiExperiment Viewer component of the TM4 microarray software 
suite50. Microarray data have been deposited in the Gene Expression Omnibus database (http://www.
ncbi.nlm.nih.gov/geo) (accession no. GSE63436).
Quantitative gene expression studies. RNA was isolated from 5 ml of GAS cells harvested under 
the desired growth phase in accordance with the RNeasy Mini kit (Qiagen) with the additional mechan-
ical lysis step in lysing matrix B tubes (MP Biomedicals). The isolated RNA was DNase treated using the 
RNase-Free DNase set (Qiagen) and quantified using a Nanodrop instrument (Thermo Scientific). 1 μ g of 
RNA was converted to cDNA using SuperScriptIII first-strand synthesis system for RT-PCR (Invitrogen). 
Real-time reverse transcriptase PCR was performed on the 1:5 diluted cDNA using the primers described 
in supplementary Table 1. The PCR reaction was performed using SYBR Green Master Mix (Applied 
Biosystems) according to manufacturer’s instructions. The reaction was performed in a ViiA7 real-time 
PCR system (Life Technologies), using the following conditions: 95 °C for 10 min, 40 cycles of 95 °C for 
15 s, and 60 °C for 1 min, and a final dissociation cycle of 95 °C for 2 min, 60 °C for 15 s, and 95 °C for 
15 s. All data was analyzed using the ViiA7 software (Life Technologies). Relative gene expression was 
calculated using the 2−ΔCT method with gyrA as the reference gene.
Growth analysis. Overnight cultures in BHP were diluted to OD600 ~ 0.05 in fresh BHP-glucose or 
BHP-galactose (in the presence of 0-100 μ M zinc). The cells were statically grown in a 96-well microtitre 
plate and OD600 measured half-hourly using the FLUOstar OPTIMA (BMG Labtech) plate reader.
Carbon metabolite assays. GAS cell cultures were grown in either BHP-Glucose or BHP-Galactose 
with or without the addition of 50 μ M zinc (a sub-inhibitory zinc concentration). Samples (2 ml) were 
collected at start-, middle- and end-exponential and stationary phase for metabolite analysis. These sam-
ples were pelleted by centrifugation (5000 g, 5 min). The resulting supernatant was filter sterilised and 
used to assay metabolite concentrations using the D-glucose, L-lactic acid, acetic acid and ethanol deter-
mination kits according following manufacturer’s instructions (Megazyme).
Enzyme activity assays. Cell free extracts were prepared from 20 ml GAS cultures grown to 
mid-exponential phase in either BHP-glucose or BHP-galactose with or without the addition of 50 μ M 
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zinc (a sub-inhibitory zinc concentration). GAS cells were pelleted, and the pellets resuspended and lysed 
in 0.5 ml of the assay buffer using the lysing matrix B (MP Biomedicals). The resultant supernatant was 
then used in the enzyme assay as follows: Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity 
was performed as previously described51. Tagatose-6-phosphate kinase (LacC.2) activity was performed 
as previously described52. Phosphofructokinase (PFK) and phophoglucomutase (PGM) activities were 
measured according to the manufacturer’s instructions (BioVision and Sigma, respectively) via a coupled 
assay linked to the generation of NADH. Enzyme activity was normalized to total protein (mg) content 
by bicinchoninic acid (BCA) assay (Sigma).
Hyaluronic acid measurement. GAS cell cultures were grown in BHP-Glucose with or without the 
addition of 25 and 50 μ M zinc until OD600 - 0.4, and samples prepared as previously described34. Total 
hyaluronic acid content was measured using the hyaluronic acid (HA) test kit according to manufactur-
er’s instructions (Corgenix), and normalized to total protein (mg) content by BCA assay (Sigma).
Statistical analysis. Differences in enzymatic activity, total metabolite and relative gene expression 
were analyzed using the 2-tailed t test (GraphPad, Prism 5).
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